Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidad

Inicio Explorar nav.journalClub Tendencias

⌘+K

Brain PET in the Diagnosis of Alzheimer’s Disease | Synapse

September 5, 2014

Brain PET in the Diagnosis of Alzheimer’s Disease

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

FDG-PET and amyloid PET imaging are valuable in the assessment of patients with Alzheimer's disease.

Preguntar a la IA

Me gusta

Guardar

Compartir

Preguntar a la IA

Me gusta

Guardar

Compartir

Cite This Study

Marcus et al. (Fri,) studied this question.

synapsesocial.com/papers/69da1a500d540cafc5838592 https://doi.org/https://doi.org/10.1097/rlu.0000000000000547

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Pathologic Correlates of Nondemented Aging, Mild Cognitive Impairment, and Early-Stage Alzheimer's Disease2001 · 515 citations
2Disease-modifying drugs in Alzheimer&#39;s disease2013 · 72 citations
3Binding Characteristics of Radiofluorinated 6-Dialkylamino-2-Naphthylethylidene Derivatives as Positron Emission Tomography Imaging Probes for β-Amyloid Plaques in Alzheimer's Disease2001 · 419 citations
4[18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer’s disease2013 · 112 citations
5[18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies2012 · 82 citations